Natera, Inc. Profile Avatar - Palmy Investing

Natera, Inc.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as tw…
Medical - Diagnostics & Research
US, San Carlos [HQ]

Cash Flow Statements

11 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
-24.00 10.00 -37.00 -73.00 -96.00 -70.00 -63.00 -182.00 -335.00 -431.00 -246.00
Operating Cash (Net)
-24.00 10.00 -37.00 -73.00 -96.00 -70.00 -63.00 -182.00 -335.00 -431.00 -246.00
Accounts Receivable
-5.00 - - - - -8.00 5.00 -18.00 2.00 -25.00 -43.00 -124.00 -33.00
Accounts Payable
6.00 -2.00 1.00 1.00 - - 3.00 -6.00 - - 19.00 5.00 -15.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-8.00 -9.00 -210.00 47.00 13.00 -5.00 -266.00 -331.00 -205.00 330.00 168.00
Capital Expenditure
-8.00 -9.00 -7.00 -23.00 -9.00 -3.00 -4.00 -19.00 -41.00 -47.00 -39.00
Purchases of Investments
- - - - -203.00 -53.00 -272.00 -170.00 -446.00 -685.00 -876.00 -86.00 -98.00
Sale/Maturity of Investment
- - - - - - 123.00 296.00 168.00 175.00 373.00 720.00 464.00 306.00
Property, Plant, Equipment (P&PE)
-8.00 -9.00 -7.00 -23.00 -9.00 -3.00 -4.00 -19.00 -41.00 -47.00 -39.00
Acquisitions (Net)
- - - - - - - - - - - - 9.00 311.00 -8.00 -378.00 - -
Other Investing Activities
- - - - - - - - - - - - -261.00 -311.00 -8.00 378.00 207.00
Financing Activities
Used Cash (Net)
-57.00 -56.00 -190.00 -13.00 -80.00 -113.00 -340.00 -500.00 -576.00 -482.00 -254.00
Debt Repayment
- - -2.00 -25.00 - - - - - - - - -78.00 - - -30.00 - -
Dividends Paid
- - - - - - - - - - - - - - - - - - - - - -
Common Stock
- - - - - - - - - - - - - - 263 537 420 239
Other Financing Activities
57.00 58.00 216.00 13.00 74.00 113.00 340.00 301.00 11.00 66.00 254.00
Cash Balances
Begin of Period
5.00 30.00 87.00 28.00 15.00 13.00 51.00 61.00 48.00 84.00 466.00
End of Period
30.00 87.00 28.00 15.00 12.00 51.00 61.00 48.00 84.00 466.00 642.00
Change
24.00 56.00 -58.00 -13.00 -2.00 37.00 10.00 -13.00 35.00 381.00 176.00
Non-Cash Balances
Depreciation and Amortization
2.00 5.00 5.00 6.00 7.00 7.00 7.00 8.00 11.00 16.00 38.00
Stock Based Compensation
1.00 5.00 7.00 10.00 11.00 14.00 28.00 50.00 115.00 152.00 191.00
Other
10.00 - - - - 2.00 1.00 2.00 8.00 14.00 48.00 31.00 -49.00
Highlighted metrics
Free Cash Flow (FCF)
-32.00 - - -45.00 -97.00 -106.00 -74.00 -68.00 -202.00 -376.00 -479.00 -286.00
Cash Conversion Cycle (CCC)
37.00 26.00 13.00 8.00 15.00 86.00 72.00 94.00 70.00 112.00 109.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of NTRA's Analysis
CIK: 1604821 CUSIP: 632307104 ISIN: US6323071042 LEI: - UEI: -
Secondary Listings
NTRA has no secondary listings inside our databases.